Olema Pharmaceuticals, Inc. (OLMA) Financials
OLMA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 276.9 million | 23.1 million |
2023-09-30 | 292.8 million | 17.7 million |
2023-06-30 | 177.6 million | 16.0 million |
2023-03-31 | 195.8 million | 20.8 million |
OLMA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -18.5 million | 4.4 million |
2023-09-30 | -22.7 million | 4.1 million |
2023-06-30 | -22.1 million | 4.2 million |
2023-03-31 | -20.4 million | 4.6 million |
OLMA Net Income
No data available :(
OLMA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 261.8 million | - | 2.4 million |
2023-09-30 | 276.9 million | - | 2.6 million |
2023-06-30 | 167.4 million | - | 2.0 million |
2023-03-31 | 186.0 million | - | 2.3 million |
OLMA Shares Outstanding
OLMA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 25.9 million | 4.5 million | 88000 |
2023-09-30 | - | 19.5 million | 3.9 million | - |
2023-06-30 | - | 18.0 million | 3.6 million | - |
2023-03-31 | - | 22.8 million | 6.8 million | - |
OLMA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 88000 |
2023-09-30 | - | 90000 |
2023-06-30 | - | 425000 |
2023-03-31 | - | 427000 |
OLMA
Price: $11.24
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -6.75
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 106400
Market Capitalization: 596.8 million